Direxion Daily S&P Biotech Bear (LABD) 16.07 $LABD
Post# of 273254
Posted On: 09/25/2016 3:08:08 PM
Direxion Daily S&P Biotech Bear (LABD) 16.07 $LABD
10 Most Read ETF Articles of the Week (August 22-26)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 26, 5:42PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the 10 most read articles of the week on ETF Trends, Aug. 22-26, 2016. Click the...
HYG: 86.76 (-0.10), USO: 10.19 (-0.34), GDXS: 15.30 (+0.75), GDJS: 1.90 (-0.10), XBI: 68.14 (-0.69), BNO: 13.56 (-0.43), IBB: 298.18 (-1.90), ZBIO: 19.51 (+0.37), XLV: 73.11 (-0.23), JNK: 36.51 (-0.08), BIS: 29.82 (+0.39), DUST: 31.84 (+2.35), XLF: 19.38 (-0.10), GDX: 27.02 (-0.72), LABD: 16.07 (+0.49), VHT: 134.76 (-0.46), JDST: 22.62 (+2.18)
Will New SEC Rules Hurt Triple Leveraged ETFs?
Sweta Killa - Zacks Investment Research - Thu Jun 09, 9:06AM CDT
The popularity of leveraged ETFs might fade in the coming months given that SEC is in the process of implementing some measures that would restrict the amount of funds that can be invested in these products.
UPRO: 73.36 (-1.16), ERY: 14.26 (+0.55), EDZ: 22.38 (+0.81), TNA: 80.53 (-1.72), SRTY: 17.63 (+0.39), FAS: 29.70 (-0.41), NUGT: 20.26 (-1.65), TQQQ: 127.67 (-2.34), LABD: 16.07 (+0.49)
Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 29.82 (+0.39), FBT: 101.88 (-0.70), XBI: 68.14 (-0.69), IBB: 298.18 (-1.90), LABD: 16.07 (+0.49)
Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 29.82 (+0.39), FBT: 101.88 (-0.70), XBI: 68.14 (-0.69), IBB: 298.18 (-1.90), LABD: 16.07 (+0.49), ZBIO: 19.51 (+0.37)
6 Inverse Leveraged ETFs Up Over 50% YTD
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 1:03PM CST
These inverse leveraged ETFs have gained at least 50% so far this year.
YANG: 14.10 (+0.69), RUSS: 10.44 (+0.47), CLAW: 32.27 (-0.23), DWTI: 85.62 (+6.71), LABD: 16.07 (+0.49), GASX: 30.78 (+2.24)
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear 3x Sha
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 8:30AM CST
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear 3x Shares
SOXS: 16.73 (+0.56), YANG: 14.10 (+0.69), DWTI: 85.62 (+6.71), LABD: 16.07 (+0.49), ZBIO: 19.51 (+0.37)
6 Inverse Leveraged ETFs Soaring to Start 2016
Sweta Killa - Zacks Investment Research - Mon Jan 11, 9:18AM CST
Inverse leveraged ETFs have provided outsized gains (over 30%) in the first week of 2016.
SOXS: 16.73 (+0.56), YANG: 14.10 (+0.69), DWTI: 85.62 (+6.71), LABD: 16.07 (+0.49), GASX: 30.78 (+2.24), ZBIO: 19.51 (+0.37)
10 Most Read ETF Articles of the Week (August 22-26)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 26, 5:42PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the 10 most read articles of the week on ETF Trends, Aug. 22-26, 2016. Click the...
HYG: 86.76 (-0.10), USO: 10.19 (-0.34), GDXS: 15.30 (+0.75), GDJS: 1.90 (-0.10), XBI: 68.14 (-0.69), BNO: 13.56 (-0.43), IBB: 298.18 (-1.90), ZBIO: 19.51 (+0.37), XLV: 73.11 (-0.23), JNK: 36.51 (-0.08), BIS: 29.82 (+0.39), DUST: 31.84 (+2.35), XLF: 19.38 (-0.10), GDX: 27.02 (-0.72), LABD: 16.07 (+0.49), VHT: 134.76 (-0.46), JDST: 22.62 (+2.18)
Will New SEC Rules Hurt Triple Leveraged ETFs?
Sweta Killa - Zacks Investment Research - Thu Jun 09, 9:06AM CDT
The popularity of leveraged ETFs might fade in the coming months given that SEC is in the process of implementing some measures that would restrict the amount of funds that can be invested in these products.
UPRO: 73.36 (-1.16), ERY: 14.26 (+0.55), EDZ: 22.38 (+0.81), TNA: 80.53 (-1.72), SRTY: 17.63 (+0.39), FAS: 29.70 (-0.41), NUGT: 20.26 (-1.65), TQQQ: 127.67 (-2.34), LABD: 16.07 (+0.49)
Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 29.82 (+0.39), FBT: 101.88 (-0.70), XBI: 68.14 (-0.69), IBB: 298.18 (-1.90), LABD: 16.07 (+0.49)
Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 29.82 (+0.39), FBT: 101.88 (-0.70), XBI: 68.14 (-0.69), IBB: 298.18 (-1.90), LABD: 16.07 (+0.49), ZBIO: 19.51 (+0.37)
6 Inverse Leveraged ETFs Up Over 50% YTD
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 1:03PM CST
These inverse leveraged ETFs have gained at least 50% so far this year.
YANG: 14.10 (+0.69), RUSS: 10.44 (+0.47), CLAW: 32.27 (-0.23), DWTI: 85.62 (+6.71), LABD: 16.07 (+0.49), GASX: 30.78 (+2.24)
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear 3x Sha
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 8:30AM CST
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear 3x Shares
SOXS: 16.73 (+0.56), YANG: 14.10 (+0.69), DWTI: 85.62 (+6.71), LABD: 16.07 (+0.49), ZBIO: 19.51 (+0.37)
6 Inverse Leveraged ETFs Soaring to Start 2016
Sweta Killa - Zacks Investment Research - Mon Jan 11, 9:18AM CST
Inverse leveraged ETFs have provided outsized gains (over 30%) in the first week of 2016.
SOXS: 16.73 (+0.56), YANG: 14.10 (+0.69), DWTI: 85.62 (+6.71), LABD: 16.07 (+0.49), GASX: 30.78 (+2.24), ZBIO: 19.51 (+0.37)
(0)
(0)Scroll down for more posts ▼